{"database": "lobbying", "table": "lobbying_activities", "rows": [[1192074, "3f75f1fe-f653-473f-8ba4-7e2c1c72c51c", "Q4", "PARRY, ROMANI, DECONCINI & SYMMS", 30792, "POZEN, INC.", 2011, "fourth_quarter", "PHA", "To provide incentives for new drug development.  No specific bills pending.", "HOUSE OF REPRESENTATIVES,SENATE", 36000, null, 0, 0, "2012-01-18T16:20:16-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1192074"], "units": {}, "query_ms": 0.8233620319515467, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}